Brief Papers
Endostatin is higher and associated with pulmonary involvement in primary Sjögren’s syndrome
Ø. Palm1, T. Ueland2, T. Garen3, A.E. Michelsen4, S. Reiseter5, P. Aukrust6, T.M. Aaløkken7, Ø. Molberg8
- Department of Rheumatology, Oslo University Hospital Rikshospitalet, Oslo, Norway. opalm@ous-hf.no
- Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet; and Institute of Clinical Medicine, University of Oslo, Norway.
- Department of Rheumatology, Oslo University Hospital Rikshospitalet, Oslo, Norway.
- Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet; and Institute of Clinical Medicine, University of Oslo, Norway.
- Department of Rheumatology, Oslo University Hospital Rikshospitalet, Oslo, Norway.
- Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet; Institute of Clinical Medicine, University of Oslo; and Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Rikshospitalet, Norway.
- Department of Radiology and Nuclear Medicine, Oslo University Hospital Rikshospitalet, Norway.
- Department of Rheumatology, Oslo University Hospital Rikshospitalet; and Institute of Clinical Medicine, University of Oslo, Norway.
CER9152
2016 Vol.34, N°4
PI 0690, PF 0693
Brief Papers
Free to view
(click on article PDF icon to read the article)
PMID: 27214260 [PubMed]
Received: 28/11/2015
Accepted : 08/02/2016
In Press: 19/05/2016
Published: 14/07/2016
Abstract
OBJECTIVES:
To investigate serum levels of endostatin in a well characterised cohort of patients with primary Sjögren’s syndrome (pSS) and healthy controls (HC) and assess associations between these mediators and clinical parameters.
METHODS:
All patients (n=144) were recruited from the Norwegian systemic connective tissue disease and vasculitis registry (NOSVAR) and fulfilled American-European classification criteria for pSS. Pulmonary involvement was based on clinical symptoms and abnormal findings on high-resolution computed tomography of the lungs. The controls were 100 healthy blood donors. Serum levels of endostatin was determined by enzyme immunoassay.
RESULTS:
We found higher mean levels of serum endostatin in patients with pSS compared with the controls (p<0.001). The patients with interstitial lung disease (ILD) had higher levels compared with those without pulmonary involvement.
CONCLUSIONS:
Our results indicate that endostatin is increased in patients with pSS and particularly in those with ILD.